| # | Title | Journal | Year | Citations |
|---|
| 1 | Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival | Journal of Neurosurgery | 2012 | 296 |
| 2 | Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes | Journal of the National Cancer Institute | 2009 | 171 |
| 3 | c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma | Annals of Oncology | 2013 | 166 |
| 4 | High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer | Human Pathology | 2008 | 147 |
| 5 | FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity | Medical Oncology | 2013 | 121 |
| 6 | Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer | Npj Breast Cancer | 2020 | 106 |
| 7 | PALB2 mutations in familial breast and pancreatic cancer | Familial Cancer | 2011 | 102 |
| 8 | Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers | Science Translational Medicine | 2017 | 96 |
| 9 | Enhancing Reproducibility in Cancer Drug Screening: How Do We Move Forward? | Cancer Research | 2014 | 90 |
| 10 | Chemotherapy and biologic therapies for melanoma: do they work? | Clinics in Dermatology | 2009 | 83 |
| 11 | Reproducibility of research and preclinical validation: problems and solutions | Nature Reviews Clinical Oncology | 2013 | 83 |
| 12 | ?-Catenin and p53 analyses of a breast carcinoma tissue microarray | Cancer | 2004 | 73 |
| 13 | Role of Chitinase 3–like-1 and Semaphorin 7a in Pulmonary Melanoma Metastasis | Cancer Research | 2015 | 71 |
| 14 | Systemic Immunotherapy for the Treatment of Brain Metastases | Frontiers in Oncology | 2016 | 66 |
| 15 | Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray | Cancer | 2006 | 63 |
| 16 | The Epothilones: Translating from the Laboratory to the Clinic | Clinical Cancer Research | 2008 | 62 |
| 17 | MEK targeting in N-RAS mutated metastatic melanoma | Molecular Cancer | 2014 | 61 |
| 18 | High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology | BMC Cancer | 2010 | 53 |
| 19 | CD70 expression patterns in renal cell carcinoma | Human Pathology | 2012 | 52 |
| 20 | Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer | Journal of Translational Medicine | 2011 | 49 |
| 21 | Chimeric Receptor mRNA Transfection as a Tool to Generate Antineoplastic Lymphocytes | Human Gene Therapy | 2009 | 48 |
| 22 | Quantitative Analysis of Breast Cancer Tissue Microarrays Shows High Cox-2 Expression Is Associated with Poor Outcome | Cancer Investigation | 2007 | 47 |
| 23 | Isolation of Epithelial, Endothelial, and Immune Cells from Lungs of Transgenic Mice with Oncogene-Induced Lung Adenocarcinomas | American Journal of Respiratory Cell and Molecular Biology | 2015 | 45 |
| 24 | Safety and Efficacy of Panitumumab Therapy After Progression With Cetuximab: Experience at Two Institutions | Clinical Colorectal Cancer | 2010 | 42 |
| 25 | Measurement of Aldehyde Dehydrogenase 1 Expression Defines a Group with Better Prognosis in Patients with Non-Small Cell Lung Cancer | American Journal of Pathology | 2012 | 41 |
| 26 | Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database | Head and Neck | 2018 | 41 |
| 27 | Pregnancy-Associated Breast Cancer | Cancer Journal (Sudbury, Mass ) | 2005 | 40 |
| 28 | Patient preferences regarding incidental genomic findings discovered during tumor profiling | Cancer | 2016 | 40 |
| 29 | Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer | Clinical Cancer Research | 2021 | 39 |
| 30 | Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma | Clinical Cancer Research | 2016 | 38 |
| 31 | High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma | Clinical Cancer Research | 2009 | 37 |
| 32 | Advances in therapy for melanoma brain metastases | Clinics in Dermatology | 2013 | 36 |
| 33 | Identification of Novel Radiosensitizers in a High-Throughput, Cell-Based Screen for DSB Repair Inhibitors | Molecular Cancer Therapeutics | 2015 | 36 |
| 34 | Chlorambucil-induced seizures | Molecular Cancer Therapeutics | 1997 | 33 |
| 35 | Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer | Breast Cancer Research and Treatment | 2007 | 33 |
| 36 | Targeted Therapy in Advanced Non-Small-Cell Lung Cancer | Seminars in Respiratory and Critical Care Medicine | 2008 | 31 |
| 37 | A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors | Cancer Chemotherapy and Pharmacology | 2012 | 31 |
| 38 | Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue | Molecular Oncology | 2014 | 29 |
| 39 | Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer | Human Pathology | 2009 | 28 |
| 40 | Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease | Cancer Medicine | 2019 | 28 |
| 41 | Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer | Cancer Chemotherapy and Pharmacology | 2000 | 26 |
| 42 | Pharmacogenetics and biomarkers in colorectal cancer | Pharmacogenomics Journal | 2009 | 26 |
| 43 | Costs associated with complications are lower with capecitabine than with 5‐fluorouracil in patients with colorectal cancer | Cancer | 2009 | 25 |
| 44 | Epothilones: tubulin polymerization as a novel target for prostate cancer therapy | Nature Clinical Practice Oncology | 2009 | 25 |
| 45 | CHI3L1 regulates PD-L1 and anti–CHI3L1–PD-1 antibody elicits synergistic antitumor responses | Journal of Clinical Investigation | 2021 | 25 |
| 46 | Evolving Immunotherapy Approaches for Renal Cell Carcinoma | Current Oncology Reports | 2016 | 24 |
| 47 | Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer | PLoS ONE | 2018 | 24 |
| 48 | Molecular classification of nonsmall cell lung cancer using a 4‐protein quantitative assay | Cancer | 2012 | 23 |
| 49 | Diminished but not dead: chemotherapy for the treatment of NSCLC | Lancet Oncology, The | 2016 | 21 |
| 50 | EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer | Annals of Oncology | 2014 | 20 |
